BANK OF AMERICA CORP /DE/ - UNITED THERAPEUTICS CORP DEL ownership

UNITED THERAPEUTICS CORP DEL's ticker is and the CUSIP is 91307CAF9. A total of 29 filers reported holding UNITED THERAPEUTICS CORP DEL in Q3 2013. The put-call ratio across all filers is - and the average weighting 0.9%.

Quarter-by-quarter ownership
BANK OF AMERICA CORP /DE/ ownership history of UNITED THERAPEUTICS CORP DEL
ValueSharesWeighting
Q3 2014$14,572,000
+220.3%
5,416,000
+124.2%
0.01%
+400.0%
Q2 2014$4,550,000
-79.8%
2,416,000
-74.6%
0.00%
-87.5%
Q4 2013$22,539,000
+218.9%
9,500,000
+128.1%
0.01%
+166.7%
Q3 2013$7,068,000
-61.3%
4,164,000
-67.0%
0.00%
-62.5%
Q2 2013$18,260,00012,620,0000.01%
Other shareholders
UNITED THERAPEUTICS CORP DEL shareholders Q3 2013
NameSharesValueWeighting ↓
Sage Capital Management, LLC 2,500,000$4,245,0004.05%
WHITEBOX ADVISORS LLC 34,365,000$58,350,0003.08%
BASSO CAPITAL MANAGEMENT, L.P. 10,000,000$16,963,0002.96%
CAMDEN ASSET MANAGEMENT L P /CA 21,257,000$36,084,0002.17%
GRACE BROTHERS MANAGEMENT LLC 1,500,000$2,549,0002.17%
Ferox Capital Management LP 3,000,000$5,101,0001.96%
Castle Creek Arbitrage, LLC 20,700,000$35,185,0001.57%
Polar Asset Management Partners Inc. 20,000,000$34,012,0001.44%
SYMPHONY ASSET MANAGEMENT LLC 7,712,000$13,091,0001.33%
Verition Fund Management LLC 2,500,000$4,256,0000.64%
View complete list of UNITED THERAPEUTICS CORP DEL shareholders